Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates. - Wikidata - wikimedia - TriplyDB

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

http://www.wikidata.org/entity/Q35087810

about

Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate.Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor.Continued rapid growth in (68) Ga applications: update 2013 to June 2014.Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.Preliminary PET/CT Imaging with Somatostatin Analogs [68Ga]DOTAGA-TATE and [68Ga]DOTAGA-TOC.

P2860

Q34119201-13DC57E6-C466-4482-9D90-4407A451A8DA Q34696158-BBE88A01-9449-472F-BBFD-23F072EE49ED Q37273212-10FE5E95-C81E-4881-AC67-C60BC3FB7D5A Q38358666-F4B641CC-3D04-4F78-A5A2-03C888A64C18 Q40925736-5FED57B0-93A7-4266-8884-F18ED3F0FDA5 Q48098858-B7DF1EB2-53A8-4477-ADFF-1F7680D96C30 Q48353671-2902AE2A-8FB5-4ADD-9E44-52AD31531D02

P2860

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

http://www.wikidata.org/entity/Q35087810

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

@ast

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

@en

type

label

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

@ast

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

@en

prefLabel

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

@ast

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

@en

P1433

Q35087810-614182CC-6B00-4158-A20F-958EA2ABE0A2

P1476

Q35087810-5E851434-AF1E-40D8-BF7B-B5FF0547A12D

P2093

Q35087810-507A3C6E-9631-41FD-88F1-4F7E529890A4

Q35087810-60F0216E-D354-4AE4-9045-0B90DA3DDADA

P2860

Q35087810-0016C0E4-1E12-4CA3-85E3-3C4A3F29B139

Q35087810-0E1519E9-D528-4C51-87A3-CB9997770ABD

Q35087810-141BEDFB-DD5E-43D9-88C6-CD2690825D87

Q35087810-1CBCC6DC-0BBE-4712-8BA4-925D5260344D

Q35087810-1FA93C79-C9EF-448C-845A-C27FAC47CC35

Q35087810-2A4DC724-B027-4A85-A9C7-B3FC10213543

Q35087810-2BF3338D-05E2-4E36-970F-0469740C00CB

Q35087810-33ADA7A6-49C5-4792-9244-657F19D28B61

Q35087810-33F813FB-0906-4665-8E9A-E5C9B105E9A2

Q35087810-342296D3-C4AE-4816-9EB2-F2927A2584B2

P2888

Q35087810-7BBA1F9D-185F-4496-81D5-539E98FD38D7

P304

Q35087810-6F15A30F-9492-4493-AA4C-452614EC6415

P31

Q35087810-E793876F-0D07-4E5F-91B2-86FEA226EA18

P356

Q35087810-EE72E0E4-B6D2-431E-AE4F-E9714BF04A62

P433

Q35087810-5A6B62E9-7DBE-490C-A451-962D1FBC3FB2

P478

Q35087810-2491A594-B174-462D-A0D5-D2C94302DF95

P50

Q35087810-4C7B6489-F431-40FE-A15D-25B1513AB3B9

P577

Q35087810-C38BE98F-E322-4D00-9827-85135C08EB4B

P698

Q35087810-3CAC8DD8-C508-4713-9560-6DC4B42A74B7

P932

Q35087810-DEC36AFC-C48D-494A-AC44-5D229FBBB897

P356

S11307-013-0627-X

P1433

Molecular Imaging and Biology

P1476

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates

@en

P2093

Mai Lin

http://www.w3.org/2001/XMLSchema#string

Michael J Welch

http://www.w3.org/2001/XMLSchema#string

P2860

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.

Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology.

Somatostatin analogs - from new molecules to new applications.

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

(68)Ga-labeled peptides in tumor imaging.

P2888

s11307-013-0627-x

P304

606-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11307-013-0627-X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23529373

http://www.w3.org/2001/XMLSchema#string

P932

4329983

http://www.w3.org/2001/XMLSchema#string